Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/15752907

Int. J. Radiat. Oncol. Biol. Phys. 2005 Mar 15 61 4 1251-7

Download in:

View as

Triples

General Info

PMID
15752907